Triple

T2138558
Position Surface form Disambiguated ID Type / Status
Subject Lucentis E46708 entity
Predicate developedBy P73 FINISHED
Object Genentech E7901 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Genentech | Statement: [Lucentis, developedBy, Genentech]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Genentech
Context triple: [Lucentis, developedBy, Genentech]
  • A. Genentech chosen
    Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
  • B. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • C. Regeneron Pharmaceuticals
    Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
  • D. Eli Lilly and Company
    Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
  • E. Biogen
    Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a88a174ab48190a5db20c132e5dccf completed March 4, 2026, 7:37 p.m.
NER Named-entity recognition batch_69abbe012aa481909ffa0a50e58efabb completed March 7, 2026, 5:56 a.m.
NED1 Entity disambiguation (via context triple) batch_69ae58d3275481909c8d74ca7c037ddd completed March 9, 2026, 5:21 a.m.
Created at: March 4, 2026, 7:44 p.m.